PPT-LYMPHOMA Medrockets.com Malignant lymphoma is a term given to tumors of the lymphoid system

and their precursor cells  The name often refers to just the  cancerous ones rather than all such tumors Many lymphomas are known to be due to specific genetic mutations 3 rd. Common (West), low-grade B-cell lymphoma. Affects elderly. Arises from germinal center B-cell. Lymphoma cells have specific translocation t(14:18), in which Bcl2 gene on chr18 fuses with . IgH. gene on chr14, causing . Cancer and Immunosuppression. . . . Pathogenesis of EBV Infection. . Cohen . NEJM 2000. Early IM: NK cells. non-HLA specific CTLs. Late IM: HLA-restricted CTLs (CD8 and CD4):. a closer look . SEER HEMATOPOIETIC DATABASE. Understanding the disease. AMBIGUOUS TERMS. Choosing . the right . Histology & TOPO CODE . Navigation of the Hematopoietic and Lymphoid Neoplasm Database . UB Department of Surgery. Grand Rounds. Craig Collins MD. Anatomy/Physiology. Pathogenesis. Background. Incidence. Risk Factors. Diagnosis. Management. Prognosis. Take Home Points. Future. Outline. Anatomy/Physiology. Prof Ivy A E . Ekem. 16. th. September 2016. Blood. en.wikipedia.org / M. . Komorniczak. . Accessed 08.09.16. Development of blood cells. en.wikipedia.org. Site of blood formation. www.healthline.com>Ref Library. lecture 3. Lecturer . Dr.Mohanad Al-Hindawi. MBCHB, MSc. Histopathology, . CABHS.Anatomical. pathology. Non-Hodgkin lymphoma-Clinical . features . Two thirds of NHLs and . (virtually all Hodgkin lymphomas) . Rouslan Kotchetkov. ,. MD, PhD. 1. , Erin Ellison, MD. 2. , . McLean J, PhD. 1. , Bryn . Pressnail, MD. 1. , Derek Nay, MD. 1. .  . 1. Simcoe . Muskoka. Regional Cancer Program. , . 2. Department . . Assistant Professor :. Dr.Maysem. . Mouayad. . Alwash. . . . Lymphocytes are the immunologically competent cells that assist the phagocytes in . defence. of the body against infection and other foreign invasion.. L, FILIPPAP, MOWAN. Primary nasal paranasaloropharyngeal lymphoma in the pediatric agegroup. Cancer 1990; 65: 1438-1444.YP, SYW,XF, ZXH, LRadiotherapy As Primary Treatment for stage IEand IIE nasal na 1 AN UPDATE OF PATHOGENETIC FEATURES WCRJ 2016; 3 (2): e715 INTRODUCTION Extra-nodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue represents approximately 8% of all non-Hodgkin 1592number patients *1 had a and 1 was by be tPretreatment whenresected was examined of Table: Relation between outcometreatment, diagnostic procedures were exclude continuoustumour growth of wall (su Gabriel Caponetti, MD, and Adam Bagg, MDDepartment of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia Feature THE JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLO - CELL LYMPHOMA DAVID NOLTE, MD (PGY - 2) HUSSAM AL - KATEB , PHD, FACMG DEBORAH FUCHS, MD OUTLINE • High grade B - cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements • Patient presen lymph nodes . Tonsils and adenoids (Waldeyer's ring) . Peyer's patches and appendix . White pulp of the spleen . Lymphadenopathy :. Localized (e.g., infection) or generalized (Systemic disease). . May be due to inflammatory, reactive or neoplastic disorders.